Tuo Xin Pharmaceutical Group Co., Ltd. (hereinafter referred to as the Group) is a high-tech enterprise integrating research and development, production, and sales of chemical synthesis, and nucleoside (acid) pharmaceutical and pharmaceutical intermediates. The Group has strong capabilities in the research, development, and production of nucleoside (acid) pharmaceutical and pharmaceutical intermediates in the domestic market.
In the field of research and development of nucleoside (acid) pharmaceutical and pharmaceutical intermediates in China, the Group has advantages such as an early start, large scale, and a complete variety, forming a relatively complete product chain from basic to high-end products. The Group has established efficient catalytic synthesis reaction technology platform, nucleoside fermentation technology platform, and bioconversion semi-synthesis technology platform. It has formed multiple series of nucleoside (acid) products, including raw materials and pharmaceutical intermediates such as cytidine choline sodium, ribavirin, adenosine, cytosine, 5-fluorocytidine, and cytidine, covering areas such as antiviral, antitumor, and neurology.
| Affiliated categories: | Adenosine Triphosphate |Choline More |
|---|